Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 1
Kratki znanstveni prispevek
Oznake: multiple sclerosis;alemtuzumab;hemophagocytic lymphohistiocytosis;side effects;neuroimmunology;drug therapy;adverse effects;
Alemtuzumab is a humanized monoclonal antibody indicated for treatment of highly active relapsing-remitting multiple sclerosis (HA-RRMS). It binds to CD52 antigen and produces a rapid and prolonged lymphocyte depletion followed by a different pattern of T and B cell repopulation. Among others, its a ...
Leto: 2023 Vir: Medicinska fakulteta (UL MF)
Št. zadetkov: 1
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: